Pulmonary disease and lung cancer

The lungs' airways and other pulmonary structures are affected by CRDs. The most common ones include chronic obstructive pulmonary disease, Air pollution, exposure to chemicals and dusts at work, and recurrent lower respiratory infections in children are other risk factors in addition to tobacco smoke. Although CRDs cannot be cured, there are numerous treatments that can assist expand the airways and reduce shortness of breath, which can help control symptoms and enhance everyday life for persons with these disorders.
Lung cancer can also deveop in lymph nodes and in other body organs. Such as the brain. There are potential risks associated with lung cancer spreading to other organs. A metastasis is the spread of cancer cells between organs.
Small cell and non-small cell lung tumors are the two primary subtypes that are typically recognised (including adenocarcinoma and squamous cell carcinoma). Various therapies are available to treat these different types of lung cancer. It is more common to develop non small cell lung cancer than small cell lung cancer.

    Related Conference of Pulmonary disease and lung cancer

    October 04-04, 2023

    6th International Conference on Rare Diseases

    Amsterdam, Netherlands
    October 09-10, 2023

    15th Euro-Global Conference on Infectious Diseases

    Zurich, Switzerland
    October 25-26, 2023

    13th International Conference on GI Disorders

    Nova Scotia, Canada
    December 07-08, 2023

    6th Pathology and Infectious Disease Conference

    Prague, Czech Republic
    February 22-23, 2024

    11th International Congress on Infectious Diseases

    Barcelona, Spain
    February 22-23, 2024

    9th Annual Summit on Rare Diseases and Orphan Drugs

    Zurich, Switzerland

    Pulmonary disease and lung cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in